Novartis AG (NVS)
161.18
+9.12
(+6.00%)
USD |
NYSE |
Sep 01, 12:02
Novartis Net Income (TTM) : 12.75B for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 12.75B |
| March 31, 2026 | 13.58B |
| December 31, 2025 | 14.02B |
| September 30, 2025 | 14.42B |
| June 30, 2025 | 13.68B |
| March 31, 2025 | 12.84B |
| December 31, 2024 | 11.92B |
| September 30, 2024 | 11.76B |
| June 30, 2024 | 10.08B |
| March 31, 2024 | 9.108B |
| December 31, 2023 | 8.575B |
| September 30, 2023 | 7.260B |
| June 30, 2023 | 7.072B |
| March 31, 2023 | 6.497B |
| December 31, 2022 | 6.561B |
| September 30, 2022 | 21.54B |
| June 30, 2022 | 22.98B |
| March 31, 2022 | 24.18B |
| December 31, 2021 | 24.02B |
| September 30, 2021 | 9.816B |
| June 30, 2021 | 8.990B |
| March 31, 2021 | 7.962B |
| December 31, 2020 | 8.076B |
| September 30, 2020 | 7.101B |
| June 30, 2020 | 7.21B |
| Date | Value |
|---|---|
| March 31, 2020 | 7.452B |
| December 31, 2019 | 7.147B |
| September 30, 2019 | 7.237B |
| June 30, 2019 | 7.089B |
| March 31, 2019 | 12.69B |
| December 31, 2018 | 12.80B |
| September 30, 2018 | 13.55B |
| June 30, 2018 | 13.74B |
| March 31, 2018 | 8.017B |
| December 31, 2017 | 7.703B |
| September 30, 2017 | 6.663B |
| June 30, 2017 | 6.525B |
| March 31, 2017 | 6.352B |
| December 31, 2016 | 6.698B |
| September 30, 2016 | 6.816B |
| June 30, 2016 | 6.683B |
| March 31, 2016 | 6.733B |
| December 31, 2015 | 7.028B |
| September 30, 2015 | 8.422B |
| June 30, 2015 | 9.712B |
| March 31, 2015 | 10.63B |
| December 31, 2014 | 11.37B |
| September 30, 2014 | 10.94B |
| June 30, 2014 | 10.03B |
| March 31, 2014 | 9.833B |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Roche Holding AG | 16.77B |
| AstraZeneca PLC | 10.40B |
| Johnson & Johnson | 21.04B |
| Eli Lilly & Co. | 26.71B |
| Merck & Co., Inc. | 3.169B |